ArticleJournal of cheminformatics2025
Multi-MoleScale: a multi-scale approach for molecular property prediction with graph contrastive and sequence learning.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In recent years, machine learning models have shown substantial progress in predicting molecular properties. However, integrating molecular graph structures with sequence information continues to present a significant challenge. In this paper, we introduce Multi-MoleScale, a novel multi-scale framework designed to address this challenge. By combining Graph Contrastive Learning (GCL) with sequence-based models like BERT, Multi-MoleScale enhances the prediction of molecular properties by capturing both structural and contextual representations of molecules. Specifically, the model leverages GCL to effectively capture the intrinsic graph-based features of molecules while utilizing BERT's pretraining capabilities to learn the contextual relationships within molecular sequences. The contrastive learning component enables Multi-MoleScale to distinguish between relevant and irrelevant molecular features, thereby enhancing its predictive accuracy across diverse molecular types. To assess the performance of our method, we conducted experiments on several widely used public datasets, including 12 molecular property datasets, the ADMET dataset, and 14 breast cancer cell line datasets. The results show that Multi-MoleScale consistently outperforms existing deep learning and self-supervised learning approaches. Notably, the model does not require handcrafted features, making it highly adaptable and versatile for a variety of molecular discovery tasks. This makes Multi-MoleScale a promising tool for applications in drug discovery, materials science, and other molecular research fields. Our data and code are available at https://github.com/pdssunny/Multi-MoleScale .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.